AR012970A1 - DRUG SUPPLY DEVICES FOR THE ADMINISTRATION OF A THERAPEUTIC AGENT - Google Patents

DRUG SUPPLY DEVICES FOR THE ADMINISTRATION OF A THERAPEUTIC AGENT

Info

Publication number
AR012970A1
AR012970A1 ARP980102783A ARP980102783A AR012970A1 AR 012970 A1 AR012970 A1 AR 012970A1 AR P980102783 A ARP980102783 A AR P980102783A AR P980102783 A ARP980102783 A AR P980102783A AR 012970 A1 AR012970 A1 AR 012970A1
Authority
AR
Argentina
Prior art keywords
acetamide
methyl
alkyl groups
group
methylformamide
Prior art date
Application number
ARP980102783A
Other languages
Spanish (es)
Original Assignee
Virodene Pharmaceutical Holdings Pty9 Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/874,425 external-priority patent/US5935597A/en
Application filed by Virodene Pharmaceutical Holdings Pty9 Ltd filed Critical Virodene Pharmaceutical Holdings Pty9 Ltd
Publication of AR012970A1 publication Critical patent/AR012970A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/10—Sulfides; Sulfoxides; Sulfones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/164—Amides, e.g. hydroxamic acids of a carboxylic acid with an aminoalcohol, e.g. ceramides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
    • A61K31/198—Alpha-aminoacids, e.g. alanine, edetic acids [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4412—Non condensed pyridines; Hydrogenated derivatives thereof having oxo groups directly attached to the heterocyclic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Abstract

Uso de una sustancia o composicion para preparar un medicamento para usar en un método de tratamiento de una infeccion viral o microbiana o un síndromede desgaste, caraterizado porque la sustancia o composicion incluye al menos uno de N,N-dimetilformamida (DMF); N-hidroximetil-N-metilformamida (HMMF);N-hidroximetilformamida (HMF); dihidroximetilformamida (DHMF); N-acetil-S- (N-metilcarbamoil) cisteína (AMCC); N-metilformamida (NMF); dimetilsulfoxido(DMSO); formamida, acetamida; metilacetamida, dimetilacetamida, dietilacetamida isopropilacetamida; diisopropilacetamida; N-acetilpiperidina; N-(beta-hidroxietil)acetamida; N,N-di (beta-hidroxietil) acetamida; N-acetilmorfolina acrilamida; propionamida; N-flluorometil-N-metil-formamida; piridin-N-oxido, ouna amida de la formula general R3-CO-NR1R2, en la cual R1 y R2 son independientemente seleccionados del grupo que consiste en H, metilo,halometilo, grupos C2-3 alquilo saturados e insaturados, y grupos alquilo hidroxilados; o R1 y R2 se seleccionan juntos del grupo que consiste en (CH2)4,(CH2)5, y (CH2)2O(CH2)2; y R3 es seleccionado del grupo que consiste en H, metilo y grupos alquilo C2-C3 saturados e insaturados; y mezclas decualesquiera dos o más delos mismos y el método inlcuye administrar el medicamento a un animal que necesita el tratamiento.Use of a substance or composition to prepare a medicament for use in a method of treating a viral or microbial infection or attrition syndrome, characterized in that the substance or composition includes at least one of N, N-dimethylformamide (DMF); N-hydroxymethyl-N-methylformamide (HMMF), N-hydroxymethylformamide (HMF); dihydroxymethylformamide (DHMF); N-acetyl-S- (N-methylcarbamoyl) cysteine (AMCC); N-methylformamide (NMF); dimethyl sulfoxide (DMSO); formamide, acetamide; methylacetamide, dimethylacetamide, diethylacetamide isopropylacetamide; diisopropylacetamide; N-acetylpiperidine; N- (beta-hydroxyethyl) acetamide; N, N-di (beta-hydroxyethyl) acetamide; N-acetylmorpholine acrylamide; propionamide; N-flluoromethyl-N-methyl-formamide; pyridin-N-oxide, or an amide of the general formula R3-CO-NR1R2, in which R1 and R2 are independently selected from the group consisting of H, methyl, halomethyl, C2-3 saturated and unsaturated alkyl groups, and alkyl groups hydroxylated; or R1 and R2 are selected together from the group consisting of (CH2) 4, (CH2) 5, and (CH2) 2O (CH2) 2; and R3 is selected from the group consisting of H, methyl, and saturated and unsaturated C2-C3 alkyl groups; and mixtures of any two or more thereof and the method includes administering the drug to an animal in need of treatment.

ARP980102783A 1997-06-13 1998-06-11 DRUG SUPPLY DEVICES FOR THE ADMINISTRATION OF A THERAPEUTIC AGENT AR012970A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/874,425 US5935597A (en) 1995-12-15 1997-06-13 Drug delivery devices and methods for treatment of viral and microbial infections and wasting syndromes

Publications (1)

Publication Number Publication Date
AR012970A1 true AR012970A1 (en) 2000-11-22

Family

ID=25363728

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP980102783A AR012970A1 (en) 1997-06-13 1998-06-11 DRUG SUPPLY DEVICES FOR THE ADMINISTRATION OF A THERAPEUTIC AGENT

Country Status (34)

Country Link
EP (1) EP1011567A1 (en)
JP (1) JP4531141B2 (en)
KR (1) KR20010013709A (en)
CN (1) CN1260703A (en)
AP (1) AP1629A (en)
AR (1) AR012970A1 (en)
AU (1) AU7831598A (en)
BG (1) BG103997A (en)
BR (1) BR9810095A (en)
CA (1) CA2295176A1 (en)
CZ (1) CZ298510B6 (en)
EA (1) EA200000011A1 (en)
EE (1) EE9900562A (en)
ES (1) ES2161187B1 (en)
FI (1) FI19992648A (en)
GB (1) GB2341319B (en)
HU (1) HUP0003034A2 (en)
ID (1) ID23516A (en)
IL (2) IL133396A0 (en)
IS (1) IS5289A (en)
LT (1) LT4714B (en)
LV (1) LV12490B (en)
NO (1) NO996117L (en)
NZ (1) NZ501669A (en)
OA (1) OA11307A (en)
PL (1) PL196256B1 (en)
RO (1) RO121252B1 (en)
SI (1) SI20191A (en)
SK (1) SK172299A3 (en)
TN (1) TNSN98086A1 (en)
TR (1) TR200000540T2 (en)
WO (1) WO1998056325A1 (en)
YU (1) YU66099A (en)
ZA (1) ZA984649B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070212402A1 (en) * 2003-12-05 2007-09-13 Rooven Qainton V Patch

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE60941B1 (en) * 1986-07-10 1994-09-07 Elan Transdermal Ltd Transdermal drug delivery device
US4855294A (en) * 1988-09-06 1989-08-08 Theratech, Inc. Method for reducing skin irritation associated with drug/penetration enhancer compositions
US5534260A (en) * 1989-02-23 1996-07-09 University Of Utah Percutaneous drug delivery system
US5028435A (en) * 1989-05-22 1991-07-02 Advanced Polymer Systems, Inc. System and method for transdermal drug delivery
US5624912A (en) * 1991-08-21 1997-04-29 Burcoglu; Arsinur Method of treating HIV infection and related secondary infections with defibrotide
KR100275843B1 (en) * 1992-02-20 2000-12-15 슈테펜엘.네스비트 Sulfonic acid derivatives and pharmacuetical composition containing the same
EE9800176A (en) * 1995-12-15 1998-12-15 Cryopreservation Technologies Cc Composition for cold storage of organs and treatment of viral and bacterial infections

Also Published As

Publication number Publication date
ES2161187B1 (en) 2003-08-16
SI20191A (en) 2000-10-31
NO996117L (en) 2000-02-11
EE9900562A (en) 2000-06-15
IS5289A (en) 1999-12-08
CZ9904473A3 (en) 2001-03-14
FI19992648A (en) 2000-02-03
EP1011567A4 (en) 2000-06-28
HUP0003034A2 (en) 2000-12-28
AP1629A (en) 2006-07-11
EA200000011A1 (en) 2000-08-28
TR200000540T2 (en) 2000-09-21
NZ501669A (en) 2001-09-28
TNSN98086A1 (en) 2005-03-15
EP1011567A1 (en) 2000-06-28
BR9810095A (en) 2001-11-13
BG103997A (en) 2001-07-31
LV12490B (en) 2000-12-20
PL338439A1 (en) 2000-11-06
NO996117D0 (en) 1999-12-10
AU7831598A (en) 1998-12-30
AP9901708A0 (en) 1999-12-31
LT99148A (en) 2000-07-25
PL196256B1 (en) 2007-12-31
ID23516A (en) 2000-04-27
WO1998056325A1 (en) 1998-12-17
OA11307A (en) 2003-10-24
RO121252B1 (en) 2007-02-28
LT4714B (en) 2000-10-25
CN1260703A (en) 2000-07-19
YU66099A (en) 2002-10-18
LV12490A (en) 2000-06-20
KR20010013709A (en) 2001-02-26
IL133396A0 (en) 2001-04-30
JP4531141B2 (en) 2010-08-25
GB9929189D0 (en) 2000-02-02
IL133396A (en) 2006-10-05
ZA984649B (en) 1999-12-17
GB2341319A (en) 2000-03-15
ES2161187A1 (en) 2001-11-16
JP2002511862A (en) 2002-04-16
GB2341319B (en) 2002-02-27
SK172299A3 (en) 2000-09-12
CZ298510B6 (en) 2007-10-24
CA2295176A1 (en) 1998-12-17

Similar Documents

Publication Publication Date Title
ES2042520T3 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING LEVODOPA METHYL ESTER, PREPARATION AND THERAPEUTIC APPLICATIONS THEREOF.
KR950002785A (en) Parathyroid hormone and raloxyphene to increase bone mass
NO992336L (en) Raf kinase inhibitors
ATE232862T1 (en) OXAZOLIDINONE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME
DE60117043D1 (en) TREATMENT OF MUCOSITIS
EA200201263A1 (en) METHODS OF TREATING INFECTIONS, CAUSED BY THE HEPATITIS DELTA VIRUS, USING β-L-2'-DEOXYNUCLEOSIDES
ES2116801T3 (en) USE OF ADAMANTANE DERIVATIVES FOR THE TREATMENT OF TINNITUS.
BR0209468A (en) Pharmaceutically acceptable compound or salts or solvates thereof, pharmaceutical composition, use of a compound, and method of treating an HPP-mediated disease or condition
AR031152A1 (en) NEW TREATMENTS FOR THE CONCERNED LEG SYNDROME
PT892794E (en) N-HYDROXYMETHYL-THALIDOMIDE PRODUTS ACIDS OF IMMUNOMODULATORY EFFECT
ES2083597T3 (en) PHARMACEUTICAL PREPARATION FOR THE TREATMENT OF PROLONGED COAGULATION TIME.
KR950703953A (en) Use of 2-amino-6-n-propylamino-4, 5, 6, 7-tetrahydrobenzothiazole (pramipexole) as an antidepressant (Use of 2-amino-6-n-propylamino-4, 5, 6, 7-tetrahydrobenzothiazole (pramipexol) as an antidepressant drug)
RU95112620A (en) Veterinary implantable preparation for animal biological rhythm regulation
ES2196049T3 (en) USE OF 2- (2-ALQUILFENILAMINO) OXAZOLINAS AND -TIAZOLINAS FOR THE MANUFACTURE OF A MEDICINAL WITH ALFA 2 ADRENERGIC EFFECT.
KR910018381A (en) Improved Ergoline-8-Carboxamide
AR012970A1 (en) DRUG SUPPLY DEVICES FOR THE ADMINISTRATION OF A THERAPEUTIC AGENT
FR2595695B1 (en) DERIVATIVES OF N - (((HYDROXY-2 PHENYL) (PHENYL) METHYLENE) AMINO-2) ETHYL) ACETAMIDE, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
ES2181702T3 (en) MELATONIN DERIVATIVES FOR USE IN THE TREATMENT OF ILLNESS IS SLEEP.
RU2011131532A (en) METHOD FOR TREATING INSOMNIA
DK0607777T3 (en) Use of leflunomide to inhibit interleukin 8
KR910004609A (en) Aminoketone derivatives and uses thereof
NO169229C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 5- (3-ALKYL-5-TERT.BUTYL-4-HYDROXYPHENYL) -2-AMINO-6H-1,3,4-THIADIAZINES
ES2135065T3 (en) DERIVATIVES OF AMIDA AND ITS THERAPEUTIC USE.
BR9815615A (en) Use of an oxazolidinone to treat psoriasis, arthritis and to reduce the toxicity of cancer chemotherapy
DK0531341T3 (en) Use of leukoregulin for the treatment of animals infected with a mantle virus

Legal Events

Date Code Title Description
FC Refusal